StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences r&d expenses

Research and development expenses are spending on new products and technology.

Vicapsys Life Sciences's R&D Expenses for the twelve months ending Sep 30, 2024 was $14.09K, down 7.7% year over year. For fiscal 2023 it was $15.27K, up 16.6% from the year before. The highest annual figure on record is $102.18K in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$15.27K+16.6%
FY2022Dec 31, 2022$13.10K-26.0%
FY2021Dec 31, 2021$17.70K-82.7%
FY2020Dec 31, 2020$102.18K+3.2%
FY2019Dec 31, 2019$98.98K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$3.75K+14.7%
Q2 FY2024Jun 30, 2024$10.00K+400.0%
Q1 FY2024Mar 31, 2024$344-96.6%
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$3.27K+5.5%
Q2 FY2023Jun 30, 2023$2.00K–
Q1 FY2023Mar 31, 2023$10.00K0.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$3.10K–
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$10.00K+333.5%
Q4 FY2021Dec 31, 2021$10.46K+28.6%
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$4.94K–
Q1 FY2021Mar 31, 2021$2.31K-97.5%
Q4 FY2020Dec 31, 2020$8.13K-91.8%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$94.05K–
Q3 FY2019Sep 30, 2019$98.98K–

More Vicapsys Life Sciences figures

See a number that looks wrong?